Lincoln Pharmaceuticals Announces Resignation of Senior Management Personnel Manoj Rai
Lincoln Pharmaceuticals Ltd · Change in Management · 24 Sept 2026, 7:38 pm
Lincoln Pharmaceuticals Announces Resignation of Senior Management Personnel Manoj Rai Lincoln Pharmaceuticals Ltd informed exchanges under SEBI LODR Regulation 30 that Manoj Rai, Senior General Manager – QA (Head QA) and designated Senior Management Personnel, has resigned due to personal reasons to pursue outside professional opportunities. His cessation took effect from the close of business hours on 24th Sep'26 following the completion of his transition period. The company has initiated steps to arrange a replacement for the quality assurance leadership role.
Original exchange filing (PDF)
More announcements from Lincoln Pharmaceuticals Ltd
- Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 29 Oct 2026
- Un-Audited Financial Results For the Quarter and Half year Ended on September 30 ,2026. · 29 Oct 2026
- Un-Audited Financial Results For the Quarter and Half Year ended on September 30, 2026. · 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 29 Oct 2026
- LINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 29 Oct 2026
- Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Standalone and Consolidated .... · 29 Oct 2026
- Change in Senior Management. · 17 Oct 2026
- with reference to the above, Please find enclosed herewith the Minutes of 32nd Annual General Meeting of the Company. · 16 Oct 2026
